Reishi Mushroom ''Extract''
.jpg)
Reishi mushroom (Ganoderma lucidum), also known as ling zhi in China is mainly prevalent in decaying logs and tree stumps. It occurs in six colours and it is mainly cultivated in East Asia and North America.
This type of mushrooms has been applied for over 2000 years in Far East for the treatment of some serious medical issues such as liver disorders, high blood pressure and arthritis. Additionally they can have a beneficial role towards diabetes, heart disease and lowering cholesterol levels. A nickname has been allocated to these mushrooms and this is ''Mushrooms of Immortality''. Their red, kidney shaped cap and their tough ''woody'' texture are associated with reduction in blood pressure, improved nerve function, enhanced stamina and weight loss.
Nowadays, cancer and diabetes are medical conditions that scientific community constantly works on. Joann Lu and Sanda Zolj, two research scientists from Bellarmine university, in Louisville, in United States of America carried an extensive investigation concerning the nutritional content of these mushrooms and their research showed that they contain important polysaccharides and saponins that decrease cell proliferation in cancerous lungs. The compounds that these mushrooms contains cause the apoptosis of cancer cells.
Recently, in China mainly there has been considerable work concerning the role of Reishi mushrooms in diabetes. Researchers from Chinese University of Hong Kong experimented reishi extracts in mice. The outcome of the study provided useful outcome as extracts from reishi lowered the blood sugar levels in the animals, which shows that it is potential that these mushrooms inhibits the production of an enzyme by the liver which leads to glucose generation.
Reishi mushrooms therefore are associated with important health benefits such as improved nutrient absorption and prevention of cancer. In extract form these mushrooms can be highly efficient otherwise stomach would not be able to digest them due to their tough texture.
No comments:
Post a Comment